Apr 14, 2026
Ro Khanna- Amount
- Receipt pending ingestion
- Filed
- May 11, 2026
Congress ticker disclosure profile
As of August 1 at 5:52 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference GENI. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
2
Disclosed ranges
Amount not disclosed
Most active member desks
10 buys vs 0 sells
Latest trade Apr 14, 2026
Apr 14, 2026
Ro KhannaApr 2, 2026
Ro KhannaMar 18, 2026
Ro KhannaMar 9, 2026
Ro KhannaFeb 24, 2026
Ro KhannaFeb 18, 2026
Ro KhannaFeb 17, 2026
Ro KhannaFeb 6, 2026
Ro KhannaFeb 5, 2026
Ro KhannaFeb 24, 2025
Ashley B. Moody| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Apr 14, 2026 | Ro Khanna | Buy | Receipt pending ingestion | May 11, 2026 | Open card |
| Apr 2, 2026 | Ro Khanna | Buy | Receipt pending ingestion | May 11, 2026 | Open card |
| Mar 18, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Apr 7, 2026 | Open card |
| Mar 9, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Apr 7, 2026 | Open card |
| Feb 24, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Mar 9, 2026 | Open card |
| Feb 18, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Mar 9, 2026 | Open card |
| Feb 17, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Mar 9, 2026 | Open card |
| Feb 6, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Mar 9, 2026 | Open card |
| Feb 5, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Mar 9, 2026 | Open card |
| Feb 24, 2025 | Ashley B. Moody | Buy | Receipt pending ingestion | Mar 22, 2025 | Receipt pending ingestion |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 0 of 10 filed rows include disclosed amount ranges (0.0%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.